Literature DB >> 9666092

Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus.

M P Cuajungco1, G J Lees.   

Abstract

Abnormal metabolism of metal ions such as zinc may contribute to neuropathology. Complexing zinc could reduce this pathology. Thus, to examine the effectiveness of metal chelating agents in vivo, a model system was used. This involved determining the ability of chelating agents to prevent neuronal death caused by zinc chloride injected into the rat hippocampus. Significant protection against zinc toxicity was obtained with pyrithione, inositol hexakisphosphate, ethylenediamine tetraacetate (EDTA) and N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN). The affinity of these agents for zinc varied between 106 M-1 and 1018 M-1. Thus, the affinity for zinc within this range does not appear to be a major factor affecting the ability of chelators to provide neuroprotection. While almost complete protection was found with EDTA and TPEN given simultaneously with zinc chloride, poor protection was obtained if TPEN was given before or after zinc chloride. Other agents either did not protect against zinc-induced neuronal death (zincon), or exacerbated zinc toxicity (BTC-5N and about 40% of rats injected with a combination of zinc chloride and diethylenetriamine pentaacetate [DTPA]). Rats showing increased damage after zinc plus BTC-5N or DTPA suffered wet dog-like shakes (WDS), suggesting that these zinc chelate complexes can induce seizures resulting in seizure-related damage. In contrast, in the 60% of rats treated with zinc chloride and DTPA that had no WDS, there was about an 80% reduction in the size of the zinc-induced lesion. The ability of chelators to cross cell membranes was examined by determining whether Timm's staining for vesicular zinc was reduced following the injection of a chelator into the hippocampus. TPEN and pyrithione reduced Timm's staining for zinc. However, cell permeability was not necessary for a chelator to protect against zinc toxicity. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666092     DOI: 10.1016/s0006-8993(98)00482-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.

Authors:  Wen Dong; Zhifeng Qi; Jia Liang; Wenjuan Shi; Yongmei Zhao; Yumin Luo; Xunming Ji; Ke Jian Liu
Journal:  Exp Neurol       Date:  2015-04-17       Impact factor: 5.330

2.  Cellular zinc levels are modulated by TRPML1-TMEM163 interaction.

Authors:  Math P Cuajungco; Luigi C Basilio; Joshua Silva; Thomas Hart; Jonathan Tringali; Cheng-Chang Chen; Martin Biel; Christian Grimm
Journal:  Traffic       Date:  2014-09-02       Impact factor: 6.215

3.  Hippocampal zinc infusion delays the development of afterdischarges and seizures in a kindling model of epilepsy.

Authors:  Siegward-M Elsas; Saman Hazany; William L Gregory; Istvan Mody
Journal:  Epilepsia       Date:  2009-01-26       Impact factor: 5.864

4.  Endogenous zinc mediates apoptotic programmed cell death in the developing brain.

Authors:  Eunsil Cho; Jung-Jin Hwang; Seung-Hee Han; Sun Ju Chung; Jae-Young Koh; Joo-Yong Lee
Journal:  Neurotox Res       Date:  2009-07-17       Impact factor: 3.911

5.  Multifunctional antioxidants for the treatment of age-related diseases.

Authors:  Hongxia Jin; James Randazzo; Peng Zhang; Peter F Kador
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

6.  Zinc overload enhances APP cleavage and Aβ deposition in the Alzheimer mouse brain.

Authors:  Chun-Yan Wang; Tao Wang; Wei Zheng; Bao-Lu Zhao; Gorm Danscher; Yu-Hua Chen; Zhan-You Wang
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

7.  Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Authors:  Satoru Oshiro; Masaki S Morioka; Masataka Kikuchi
Journal:  Adv Pharmacol Sci       Date:  2011-10-12

Review 8.  Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Fatemeh Eshraghi Jazi; Bahar Mazaheri; Maryam Moeini; Tahereh Safari; Fariba Azarkish; Fatemeh Moslemi; Maryam Maleki; Alireza Rezaei; Shadan Saberi; Aghdas Dehghani; Maryam Malek; Azam Mansouri; Marzieh Ghasemi; Farzaneh Zeinali; Zohreh Zamani; Mitra Navidi; Sima Jilanchi; Soheyla Shirdavani; Farzaneh Ashrafi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

9.  Transmembrane 163 (TMEM163) protein effluxes zinc.

Authors:  Vanessa B Sanchez; Saima Ali; Adrian Escobar; Math P Cuajungco
Journal:  Arch Biochem Biophys       Date:  2019-11-04       Impact factor: 4.013

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.